Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma.
Alyce Mei-Shiuan KuoHani HassounUrvi ShahAllison GordonTravis J HollmannHeather J LandauCecilia LezcanoSham MailankodyCarlyn C TanAlexander M LesokhinAlina MarkovaPublished in: Leukemia & lymphoma (2022)